Literature DB >> 10323829

Intranasal corticosteroids in allergic rhinitis. Paper did not include all data on adverse effects.

D Paddon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10323829      PMCID： PMC1115725     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  QT lengthening and life-threatening arrhythmias associated with fexofenadine.

Authors:  Y M Pinto; I C van Gelder; M Heeringa; H J Crijns
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321

2.  Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions.

Authors:  C A Findlay; J F Macdonald; A M Wallace; N Geddes; M D Donaldson
Journal:  BMJ       Date:  1998-09-12

3.  Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials.

Authors:  J M Weiner; M J Abramson; R M Puy
Journal:  BMJ       Date:  1998-12-12

4.  Problem setting and problem solving: the role of evidence-based medicine.

Authors:  C Paterson
Journal:  J R Soc Med       Date:  1997-06       Impact factor: 5.344

5.  Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children.

Authors:  O D Wolthers; S Pedersen
Journal:  Allergy       Date:  1994-02       Impact factor: 13.146

6.  Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids.

Authors:  O D Wolthers; S Pedersen
Journal:  Acta Paediatr       Date:  1993-08       Impact factor: 2.299
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.